Structural and functional implications of C-terminal regions of alpha-synuclein - PubMed (original) (raw)
. 2002 Nov 19;41(46):13782-90.
doi: 10.1021/bi026284c.
Affiliations
- PMID: 12427041
- DOI: 10.1021/bi026284c
Structural and functional implications of C-terminal regions of alpha-synuclein
Thomas D Kim et al. Biochemistry. 2002.
Abstract
Aggregation of alpha-synuclein is thought to play a major role in the pathogenesis of Parkinson's disease (PD), which is characterized by the presence of intracytoplasmic Lewy bodies (LB) in the brain. alpha-Synuclein and its deletion mutants are largely unfolded proteins with random coil structures as revealed by CD spectra, fluorescence spectra, gel filtration chromatography, and ultracentrifugation. On the basis of its highly unfolded and flexible conformation, we have investigated the chaperone-like activity of alpha-synuclein in vitro. In our experiments, alpha-synuclein inhibited the aggregation of model substrates and protected the catalytic activity of alcohol dehydrogenase and rhodanese during heat stress. In addition, alpha-synuclein inhibited the initial aggregation of reduced/denatured lysozyme on the refolding pathway. Interestingly, deletion of the C-terminal regions led to the abolishment of chaperone activity, although largely unstructured conformations are maintained. Moreover, alpha-synuclein could inhibit the aggregation of various Escherichia coli cellular proteins during heat stress, and C-terminal deletion mutants could not provide any protection to these cellular proteins. Results with synthetic C-terminal peptides and C-terminal deletion mutants suggest that the second acidic repeat, (125)YEMPSEEGYQDYEPEA(140), is important for the chaperone activity of alpha-synuclein, and C-terminal deletion leads to the facilitated aggregation with the elimination of chaperone activity.
Similar articles
- Distinct roles of the N-terminal-binding domain and the C-terminal-solubilizing domain of alpha-synuclein, a molecular chaperone.
Park SM, Jung HY, Kim TD, Park JH, Yang CH, Kim J. Park SM, et al. J Biol Chem. 2002 Aug 9;277(32):28512-20. doi: 10.1074/jbc.M111971200. Epub 2002 May 24. J Biol Chem. 2002. PMID: 12032141 - Effects of novel peptides derived from the acidic tail of synuclein (ATS) on the aggregation and stability of fusion proteins.
Park SM, Ahn KJ, Jung HY, Park JH, Kim J. Park SM, et al. Protein Eng Des Sel. 2004 Mar;17(3):251-60. doi: 10.1093/protein/gzh029. Epub 2004 Apr 5. Protein Eng Des Sel. 2004. PMID: 15067107 - Structure/function in neuroprotection and apoptosis.
Borden KL. Borden KL. Ann Neurol. 1998 Sep;44(3 Suppl 1):S65-71. doi: 10.1002/ana.410440711. Ann Neurol. 1998. PMID: 9749576 Review. - N-terminal fusion potentiates α-synuclein secretion [correction].
Falkenburger BH. Falkenburger BH. Cell Mol Neurobiol. 2018 Nov;38(8):1551-1554. doi: 10.1007/s10571-018-0621-6. Epub 2018 Oct 4. Cell Mol Neurobiol. 2018. PMID: 30288630 Review. No abstract available.
Cited by
- CP12 from Chlamydomonas reinhardtii, a permanent specific "chaperone-like" protein of glyceraldehyde-3-phosphate dehydrogenase.
Erales J, Lignon S, Gontero B. Erales J, et al. J Biol Chem. 2009 May 8;284(19):12735-44. doi: 10.1074/jbc.M808254200. Epub 2009 Mar 14. J Biol Chem. 2009. PMID: 19287002 Free PMC article. - The chaperone-like activity of α-synuclein attenuates aggregation of its alternatively spliced isoform, 112-synuclein in vitro: plausible cross-talk between isoforms in protein aggregation.
Manda KM, Yedlapudi D, Korukonda S, Bojja S, Kalivendi SV. Manda KM, et al. PLoS One. 2014 Jun 3;9(6):e98657. doi: 10.1371/journal.pone.0098657. eCollection 2014. PLoS One. 2014. PMID: 24892822 Free PMC article. - Evidence for Intramolecular Antiparallel Beta-Sheet Structure in Alpha-Synuclein Fibrils from a Combination of Two-Dimensional Infrared Spectroscopy and Atomic Force Microscopy.
Roeters SJ, Iyer A, Pletikapić G, Kogan V, Subramaniam V, Woutersen S. Roeters SJ, et al. Sci Rep. 2017 Jan 23;7:41051. doi: 10.1038/srep41051. Sci Rep. 2017. PMID: 28112214 Free PMC article. - The potential of natural products to inhibit abnormal aggregation of α-Synuclein in the treatment of Parkinson's disease.
Yang K, Lv Z, Zhao W, Lai G, Zheng C, Qi F, Zhao C, Hu K, Chen X, Fu F, Li J, Xie G, Wang H, Wu X, Zheng W. Yang K, et al. Front Pharmacol. 2024 Oct 23;15:1468850. doi: 10.3389/fphar.2024.1468850. eCollection 2024. Front Pharmacol. 2024. PMID: 39508052 Free PMC article. Review. - Neurons and Glia Interplay in α-Synucleinopathies.
Mavroeidi P, Xilouri M. Mavroeidi P, et al. Int J Mol Sci. 2021 May 8;22(9):4994. doi: 10.3390/ijms22094994. Int J Mol Sci. 2021. PMID: 34066733 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous